Plain-English translation of NCT02986984 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand why diabetic kidney disease develops differently in different people — and why current treatments don't work well for everyone. This study collects kidney tissue samples from people with diabetes who are already scheduled for a kidney biopsy for medical reasons. By studying these samples directly from human kidneys (rather than relying only on animal studies or genetic research), scientists hope to discover new ways to prevent and treat kidney damage caused by diabetes.
For 15 years, no new medications have been approved to treat diabetic kidney disease. Animal studies and genetic research haven't led to breakthroughs, so researchers need to study real human kidney tissue to understand what goes wrong and develop better treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, your participation mainly involves allowing researchers to study your kidney tissue sample that is already being collected as part of your scheduled biopsy. You will also be asked to participate in follow-up visits at the study clinic to share medical information and answer questions about your health. The study is looking to enroll about 400 people total and will compare kidney tissue from people whose diabetes caused kidney damage to those whose diabetes did not.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States